LexDanaLexDanabeta
Inventor

John R. McCullough

Inventor
Worcester, MA, US

Overview

46→
Patents
1976–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 46 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
B64CAeroplanes9%
B64DEquipment for fitting in or to aircraft6%
B64UUnmanned aerial vehicles [uav]6%
C07DHeterocyclic compounds6%
C07CAcyclic or carbocyclic compounds3%
C02FTreatment of water, waste water, sewage, or sludge2%
C07BGeneral methods of organic chemistry2%
G05DSystems for controlling or regulating non-electric variables2%
PatentTitleYear
11,027,837Aircraft having thrust to weight dependent transitions202111,027,834Inboard centrifugal force bearing attachment202111,008,102Maneuverable capture apparatus for airborne deployment and retrieval of parasite aircraft202110,994,835Inertia weight assemblies for rotorcraft202110,981,661Aircraft having multiple independent yaw authority mechanisms202110,981,647Rotor span-balance pocket202110,913,541Aircraft having redundant directional control202110,906,520Airbag to secure payload202110,906,637Assisted landing systems for rotorcraft20217,214,683'Compositions of descarboethoxyloratadine'20077,214,684'Methods for the treatment of allergic rhinitis'20077,211,582'Methods for treating urticaria using descarboethoxyloratadine'20076,632,827'Compositions of optically pure () norcisapride'20036,495,605'Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure ()-bupropion'20026,458,374'Methods and compositions for treating chronic disorders using optically pure ()-bupropion'20026,455,530'2R,4S,S,S- and 2S,4R,S,S-hydroxyitraconazole'20026,342,496'Bupropion metabolites and methods of use'20026,313,144'Compositions of optically pure (-) norcisapride'20016,242,465'Compositions of optically pure (+) norcisapride'20016,207,681'Methods and compositions for treating urinary incontinence using enantiomerically enriched (R)-trihexyphenidyl'20016,204,285'Methods and compositions for treating urinary incontinence using enantiomerically enriched (R,R)-glycopyrrolate'20016,166,018'2R, 4S, R, S- and 2S, 4R, R, S-hydroxyitraconazole'20006,156,770'Compositions of optically pure (-) norcisapride and another therapeutic agent'20006,147,093'Methods for treating gastroesophageal reflux disease'20006,130,242'S-procyclidine for treating urinary incontinence'20006,114,356'Method for treating gastrointestinal disorders using (+) norcisapride'20006,110,972'Methods and compositions for treating urinary incontinence using enantiomerically enriched (S)-tridihexethyl'20006,063,808'Methods and compositions for treating urinary incontinence using enantiomerically enriched (S,S)-glycopyrrolate'20006,063,792'Methods and compositions for treating urinary incontinence using enantiomerically enriched (S)-trihexyphenidyl'20005,952,502'2R,4S,R, S- and 2S,4R,R,S-hydroxyitraconazole'19995,939,426'Methods for treating urinary incontinence using descarboethoxyloratadine'19995,877,189'Methods for treating central nervous system disorders and other disorders using optically pure (-) norcisapride'19995,877,188'Methods for treating central nervous system disorders using optically pure (+) norcisapride'19995,807,541'NSAID/fluoride periodontal compositions and methods'19985,739,151'Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride'19985,736,577'Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin'19985,731,319'Methods for treating disorders using descarboethoxyloratadine'19985,712,293'Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride'19985,677,346'Treating urinary incontinence using (S)-desethyloxybutynin'19975,620,892'Strain of Saccharomyces cerevisiae expressing the gene encoding potassium transporter minK'19975,595,997'Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine'19975,532,278'Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin'19965,011,837'Aryl cyanoguanidines: potassium channel activators and method of making same'1991D0259208'Roof vent'19814,048,072'Air diffusers'19773,966,854'Air trap'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976–1977Patents assigned to SCHRAMM INC (2)· patent assignee history
1976–1977Based in West Chester, PA, US· patent location history
1991–1997Based in Newtown, PA, US· patent location history
1996–2007Patents assigned to SEPRACOR INC (32)· patent assignee history
1996–2007Based in Worcester, MA, US· patent location history
1998–2007Patents assigned to UNIV MASSACHUSETTS (3)· patent assignee history
2000–2003Based in Hudson, MA, US· patent location history
2021Patents assigned to TEXTRON INNOVATIONS INC (7)· patent assignee history
2021Patents assigned to BELL HELICOPTER TEXTRON INC (2)· patent assignee history
2021Based in Weatherford, TX, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SEPRACOR INC321996–2007
TEXTRON INNOVATIONS INC72021
UNIV MASSACHUSETTS31998–2007
BELL HELICOPTER TEXTRON INC22021
SCHRAMM INC21976–1977
Locations
LocationPatentsSpan
Worcester, Massachusetts, US201996–2007
Hudson, Massachusetts, US122000–2003
Weatherford, Texas, US82021
Newtown, Pennsylvania, US21991–1997
West Chester, Pennsylvania, US21976–1977